Regeneron Pharmaceuticals, Inc.
Fascin-2 (FSCN2) Variants And Uses Thereof

Abstract:

The present disclosure provides methods of treating subjects having hearing loss, methods of identifying subjects having an increased risk of developing hearing loss, and methods of detecting human Fascin-2 (FSCN2) variant nucleic acid molecules and variant polypeptides.